Evidence map›Paper›PMID 40294033›Full record

ArticlePloS one2025

Prevalence of multimorbidity and its relationship with socioeconomic status among Chinese older adults over time.

Qin Liu, Jiehua Lu

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Qin LiuResearch Institute of Social Development, Southwestern University of Finance and Economics, Chengdu, China.ORCID https://orcid.org/0009-0008-1577-0282
Jiehua LuDepartment of Sociology, Peking University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies linking socioeconomic status (SES) to chronic diseases tended to focus on a single disease. As people age, they are more likely to suffer from multiple coexisting chronic conditions, known as multimorbidity. The study of multimorbidity is one of the key links to understanding the impact of population ageing from a comprehensive perspective. This study used four waves of cross-sectional data from the China Health and Retirement Longitudinal Study (CHARLS) from 2011 to 2018 to explore the prevalence of multimorbidity and its relationship with socioeconomic status among older adults in China over time. Participants aged 60 and older were selected for analysis. Both the Logistic Regression Model and the Negative Binomial Regression Model were adopted to examine the relationship between socioeconomic status and multimorbidity. The results showed that the prevalence of multimorbidity among older adults in China demonstrated an increasing trend over the years, from 46.16% in 2011 to 57.50% in 2018. A significant association was detected between socioeconomic status and multimorbidity among older adults, which was manifested as the higher the socioeconomic status, the greater the likelihood of being multimorbid. However, the relationship between the two has been changing over time, with the influence of SES on multimorbidity gradually disappearing and then reappearing in the opposite direction. Multimorbidity has become a critical health issue that should not be ignored for older adults in China, and the relationship between socioeconomic status and multimorbidity may be changing over time, which needs to be further explored with data over a longer period of time.

Indexed as

MultimorbiditySocial ClassAgedAged, 80 and overChinaChronic DiseaseCross-Sectional StudiesEast Asian PeopleFemaleHumansLongitudinal StudiesMaleMiddle AgedPrevalence

Identifiers

PMID40294033
PMCPMC12036900

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.